# Difference-in-Differences Analysis Results - Test ID: ahhcuJnMV1

## Analysis Overview

### Test Configuration
- **Test ID**: ahhcuJnMV1
- **Experiment Period**: May 20-26, 2026 (7 days)
- **Pre-experiment Period**: May 6-19, 2026 (14 days)
- **Population**: "During users" - users active during the experiment period
- **Metric**: Daily average revenue per user (true daily average across full periods)

### Sample Sizes
- **Test Group**: 447,513 users
- **Control Group**: 111,917 users
- **Total**: 559,430 users

## Key Findings Summary

**The Difference-in-Differences analysis shows no statistically significant treatment effect.**

- **Treatment Effect**: -$0.020 per user per day (-1.57%)
- **95% Confidence Interval**: [-5.36%, +2.22%]
- **Statistical Significance**: Not Significant
- **Interpretation**: The Test group experienced a slightly smaller increase in daily revenue compared to the Control group, but this difference is not statistically distinguishable from zero.

## Summary of Main Results

| Metric | Value |
|--------|-------|
| **Method** | Diff-in-Diff |
| **Treatment Effect (Absolute)** | -$0.019872 |
| **Treatment Effect (%)** | -1.57% |
| **95% CI (%)** | [-5.36%, +2.22%] |
| **Statistical Significance** | Not Significant |
| **Standard Error** | $0.02444383 |

## Detailed Statistical Results

### Group-Level Period Averages

| Group | Before Period | During Period | Change |
|-------|---------------|---------------|---------|
| **Test** | $1.319922 | $1.349588 | +$0.029666 |
| **Control** | $1.264595 | $1.314133 | +$0.049538 |

### Change Score Analysis

- **Test Group Mean Change**: +$0.029666 per user per day
- **Control Group Mean Change**: +$0.049538 per user per day
- **Difference-in-Differences**: $0.029666 - $0.049538 = **-$0.019872**

### Statistical Inference

- **Treatment Effect**: -$0.019872 per user per day
- **Standard Error**: $0.02444383
- **95% Confidence Interval**: [-$0.067782, +$0.028038]
- **t-statistic**: -0.813 (not significant at α = 0.05)

### Percentage Analysis (Control Baseline = $1.264595)

- **Treatment Effect**: -1.57% of control baseline
- **95% CI Lower Bound**: -5.36%
- **95% CI Upper Bound**: +2.22%

## Diff-in-Diff Effectiveness Assessment

### Methodology Summary
**Difference-in-Differences**: Estimates treatment effects by comparing the change in outcomes between treatment and control groups over time, effectively removing common time trends and external factors.

### Key Results
- **Treatment Effect**: -$0.020 (-1.57%)
- **Statistical Power**: Sufficient sample size but effect not significant
- **Interpretation**: No evidence of treatment effect after controlling for time trends

### Statistical Assessment

**Parallel Trends Assumption**: Both groups experienced positive revenue changes during the experiment period, with similar baseline levels, supporting the parallel trends assumption underlying Diff-in-Diff.

**Effect Size**: The observed treatment effect is small (-1.57%) and not statistically significant, suggesting:
1. The treatment may have no meaningful effect
2. The treatment effect may be too small to detect with current sample size and variance
3. Both groups were affected similarly by external factors during the experiment period

## Comparison with Time Trends

### Natural Change Patterns
- **Test Group**: Experienced a +$0.030 natural increase
- **Control Group**: Experienced a +$0.050 natural increase  
- **Diff-in-Diff Insight**: After accounting for this natural trend difference, the treatment appears to have reduced the rate of revenue increase by $0.020 per user per day

### Economic Interpretation

The Diff-in-Diff analysis suggests that:

1. **Both groups experienced revenue increases** during the experiment period, likely due to external factors (seasonal effects, marketing campaigns, game updates, etc.)

2. **The Control group's increase was larger** (+$0.050 vs +$0.030), leading to a negative treatment effect estimate

3. **The treatment may have dampened** the natural revenue growth that would have occurred without intervention

4. **No statistical significance** means we cannot conclusively determine whether this difference represents a true treatment effect or random variation

## Confidence Interval Interpretation

The 95% confidence interval [-5.36%, +2.22%] indicates:

- **Lower bound**: Treatment could reduce daily revenue by up to 5.36%
- **Upper bound**: Treatment could increase daily revenue by up to 2.22%
- **Includes zero**: No statistically significant treatment effect
- **Range**: The true effect could plausibly be anywhere within this 7.58 percentage point range

## Methodological Notes

### Population Definition
- **"During Users"**: Only includes users who were active during the experiment period (May 20-26, 2026)
- **No Selection Bias**: Users without pre-period activity receive avg_rev_before = 0 rather than being excluded

### Revenue Calculation
- **True Daily Average**: SUM(gross_rev) / total_days, not AVG(gross_rev per active day)
- **Consistent Periods**: 14-day pre-period vs 7-day experiment period, properly normalized

### Statistical Method
- **User-Level Change Scores**: Variance calculated on user_diff = during - before
- **Standard Error**: Accounts for different group sizes and within-group variance
- **Confidence Intervals**: Based on normal approximation with 95% coverage

## Business Implications

1. **No Clear Treatment Effect**: The analysis provides no evidence that the treatment meaningfully affected user revenue behavior

2. **Natural Revenue Growth**: Both groups showed positive revenue trends, suggesting favorable external conditions during the experiment

3. **Precision Concerns**: The relatively wide confidence interval suggests that smaller effects (< 2-3%) may be difficult to detect reliably with current methodology

4. **Control Group Performance**: The Control group's stronger natural growth pattern may warrant investigation for potential insights

## Recommendations

1. **Extend Analysis Period**: Longer experiment duration may help detect smaller effects and reduce confidence interval width

2. **Investigate Control Trends**: Understanding why the Control group showed stronger natural growth could provide business insights

3. **Effect Size Planning**: For future experiments, consider the minimum detectable effect size given current variance levels

4. **Complementary Analyses**: Consider additional metrics (conversion rates, engagement, etc.) that might show treatment effects not visible in revenue alone